Depression vulnerability within smoking research: How accurate are one-item screening items? by McChargue, Dennis E. & Werth Cook, Jessica
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Faculty Publications, Department of Psychology Psychology, Department of 
January 2007 
Depression vulnerability within smoking research: How accurate 
are one-item screening items? 
Dennis E. McChargue 
University of Nebraska-Lincoln, dmcchargue2@unl.edu 
Jessica Werth Cook 
VA Puget Sound Health Care System-Seattle Division, Seattle, United States 
Follow this and additional works at: https://digitalcommons.unl.edu/psychfacpub 
 Part of the Psychiatry and Psychology Commons 
McChargue, Dennis E. and Werth Cook, Jessica, "Depression vulnerability within smoking research: How 
accurate are one-item screening items?" (2007). Faculty Publications, Department of Psychology. 269. 
https://digitalcommons.unl.edu/psychfacpub/269 
This Article is brought to you for free and open access by the Psychology, Department of at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Faculty Publications, 
Department of Psychology by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. 
Short Communication
Depression vulnerability within smoking research:
How accurate are one-item screening items?
Dennis E. McChargue a,b,⁎, Jessica Werth Cook c
a University of Nebraska-Lincoln, 238 Burnett Hall, P.O. Box 880308, Lincoln, NE 68588-0308, United States
b University of Illinois at Chicago, Chicago, United States
c VA Puget Sound Health Care System-Seattle Division, Seattle, United States
Abstract
Epidemiological and large scale treatment studies within smoking research have utilized many one-item
screening items to examine the influence of current depressive symptoms on smoking behavior and quitting. Little
is known about that concurrent validity of screening items that may reflect depression vulnerability independent of
current symptoms. The present paper evaluated the concurrent validity of two one-item screening items that were
essential for diagnosing past episodes of major depression. Screening questions were administered to seventy-
seven nicotine dependent participants via a telephone screening interview. Smokers then returned to the laboratory
for a comprehensive structured assessment of depressive vulnerability. Vulnerability measures were clinician-
diagnosed history of major depressive disorder and other self-reported depressive vulnerability factors. Telephone
screening items accurately classified a clinician-diagnosed history of major depression, and predicted the number
of recurrent depressive episodes, self-reported rumination, and self-reported depression-proneness (all p<0.05).
Results support the utility of one-item screening questions as a “proxy” of a depressive vulnerability for smoking
treatment studies that are not designed for comprehensive assessment procedures.
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1. Introduction
Relatively asymptomatic smokers with a history of major depressive disorder (MDD Hx) have been a
targeted subpopulation within smoking research. Structured interviews to assess depressive vulnerability
are traditionally employed within such studies (e.g., Hitsman, Borrelli, McChargue, Spring, & Niaura,
2003). With few exceptions (Niaura et al., 1999), one-item depression scales have yet to potentially
approximate (proxy) MDD vulnerability beyond current depressive symptoms (e.g., Hughes, 1992). The
purpose of the present study was to examine the concurrent validity of two one-item “proxies” of MDD
vulnerability among euthymic smokers.
MDD vulnerability was defined as consisting of a cluster of stable, endogenous and latent
characteristics (Ingram & Price, 2001), which include clinician-diagnosed past MDD episodes, self-
reported depression proneness, trait-anhedonia, and ruminative coping styles. Such endogenous and
stable factors have been reflective of either a latent response to MDD episodes or predictive of future
MDD exacerbations (Just & Alloy, 1997; Lewinsohn, Rohde, Seeley, Klein, & Gotlib, 2000; Loas, 1996).
We hypothesized that one-item endorsement would be associated with greater numbers of clinician-
diagnosed MDD Hx, higher self-reported depressive proneness scores, trait-anhedonia, and ruminative
coping styles among a sample of smokers.
2. Methods
2.1. Participants
Seventy-seven smokers (34.6% male) participated in the present study. On average, participants were
40.65years old (S.D.=10.39). The sample was 65.1% African American, 1.3% Asian, 28.2% Caucasian,
3.8% Latino, and 1.3%multicultural. Forty percent received a high school education or less, 49% reported
some college or trade school, 6.5% reported a Bachelor's degree, and 3.9% reported obtaining a graduate
degree or higher. On average, the participants reported smoking 20.32 (S.D.=6.67) cigarettes per day,
smoked for the past 22.16years (S.D.=10.59), and reported an average dependence score of 4 (S.D.=
1.37) as measured by the Fagerström Test for Nicotine Dependence (Heatherton, Kozlowski, Frecker, &
Fagerström, 1991). Participants were excluded if they had a medically unstable condition or had current
MDD or any other axis I disorder other than nicotine dependence. Women with late gluteal phase disorder
or severe premenstrual disturbance were also excluded.
2.2. Measures
2.2.1. One-item screening questions
To assess for the likelihood of a MDD Hx, participants were asked via telephone: (1) Have you ever
been down or depressed most of the day nearly everyday for 2weeks or more (depression screen), and (2)
Have you ever lost interest or pleasure in things you typically enjoy most of the day nearly everyday for
2weeks or more (anhedonia screen). These items were chosen for the screen because the structure of such
questions may increase our psychometric specificity by referencing a 2-week period of consecutive days
of depression or loss of pleasure at any time in the persons life as opposed to the traditional momentary
and situationally specific assessment of current depressive symptoms. Clinicians that conducted the
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structured interviews were blind to the participants' endorsement status of the telephone screening
questions.
2.2.2. MDD vulnerability measures
The Structured Clinical Interview for DSM-IV-Nonpatient version (SCID-NP; Spitzer, Williams,
Gibbon, & First, 1992) was administered by a trained clinician to rule out current axis I disorders other
than nicotine dependence and to identify the number of past MDD episodes. The Fawcett-Clark Pleasure
Scale (FCPS; Fawcett, Clark, Scheftner, & Gibbons, 1983) measured trait anhedonia. The Response Style
Questionnaire (RSQ; Nolen-Hoeksema, 1991) was used to measure dispositional ruminative responses to
dysphoric mood. Lastly, the Depression Proneness Inventory (DPI; Zemore, 1983) was used to assess
proneness to depression.
Fig. 1. Classification table for chi-square analysis examining whether the one-item depression screening question predicted
clinician diagnosed history of depression.
Fig. 2. Classification table for chi-square analysis examining whether the one-item anhedonia screening question predicted
clinician diagnosed history of depression.
406 D.E. McChargue, J. Werth Cook / Addictive Behaviors 32 (2007) 404–409
2.3. Procedure
2.3.1. Screening assessment
Assenting candidates' demographic information, smoking history, and the two one-item MDD Hx
screens were gathered via a telephone interview. During a subsequent laboratory visit, a trained clinician
collected informed consent and conducted the SCID-NP diagnostic interview. Scales assessing MDD
vulnerability factors (FCPS, DPI, RSQ) were also disseminated.
3. Results
3.1. Classification of clinician-diagnosed MDD history
Chi-square analysis was significant between the depression screen and clinician-diagnosed MDD Hx
[χ2(1, N=77)=31.89, p<0.01]. The depression screen correctly classified 81% of the clinician-
diagnosed history of MDD (see Fig. 1). Chi-square analysis also revealed a significant relationship
between the anhedonia screen and clinician-diagnosed MDD Hx [χ2(1, N=77)=8.11, p<0.01], where
65% of the participants were classified correctly (see Fig. 2 and Table 1).1
3.2. Screening items and number of MDD episodes
After controlling for nicotine dependence and ethnicity, analysis of covariance (ANCOVA) showed a
main effect for the depression screen [F(1,68)=20.77, p=0.00, η2 =0.23] and the anhedonia screen [F
(1,68)=9.00, p=0.004, η2 =0.12] on number of past MDD episodes, and neither of these effects were
moderated by gender (see Table 2).
Table 1
Intercorrelations among predictor and criterion variables (N=78)
1 2 3 4 5 6 7 8 9 10
1. Depression screen item –
2. Anhedonia screen item 0.58⁎⁎ –
3. Gender 0.02 −0.11 –
4. SCID history of depression 0.64⁎⁎ 0.33⁎⁎ 0.12 –
5. Number depressive episodes 0.48⁎⁎ 0.24⁎ 0.09 0.63⁎⁎ –
6. Rumination 0.40⁎⁎ 0.41⁎⁎ −0.07 0.41⁎⁎ 0.45⁎⁎ –
7. Depression proneness 0.42⁎⁎ 0.44⁎⁎ 0.01 0.48⁎⁎ 0.51⁎⁎ 0.70⁎⁎ –
8. Anhedonia 0.06 0.04 0.06 −0.04 −0.07 −0.04 −0.32⁎⁎ –
9. Ethnicity 0.30⁎ 0.01 0.11 0.10 0.10 0.05 0.02 0.12 –
10. Nicotine Dependence 0.23⁎ 0.13 −0.08 0.14 0.14 0.31⁎⁎ 0.30⁎⁎ −0.27⁎ −0.26⁎ –
⁎⁎p<0.01, ⁎p<0.05, ⁎one-tailed.
1 As shown in Table 1, the depression and anhedonia screen questions were significantly correlated [r=0.58, p<0.01],
suggesting that the two items measure related but distinct constructs.
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3.3. Screening items and other depressive vulnerability constructs
ANCOVA showed a main effect for the depression screen on rumination [F(1,72)=15.84, p=0.00,
η2 =0.19] and the depression screen question significantly interacted with gender [F(1,72)=7.01,
p=0.01, η2 =0.09]. Simple effects analyses revealed that males [p=0.001] and not females [p=0.23] who
endorsed the depression screen reported greater rumination [p=0.001] (see Fig. 3). The anhedonia screen
also significantly influenced rumination [F(1,72)=15.14, p=0.00, η2 =0.18], but did not interact with
gender [p=0.12] (see Table 2).
ANCOVA also showed that the depression screen [F(1,72)=17.05, p=0.00, η2 =0.20] and the
anhedonia screen [F(1,72)=17.48, p=0.00, η2 =0.21] had a main effect on DPI scores, and these effects
were not moderated by gender (see Table 2). Neither screening item predicted FCPS [both p's=ns].
4. Discussion
Results show a moderate level of support for the utility of a brief, telephone assessment for MDD
vulnerability. The depression screen and the anhedonia screen correctly classified a positive history of
depression in 73% and 63% of study participants, respectively. Whereas, such questions more accurately
classified the absence of a clinically diagnosed MDD Hx 89% of the time for the depression screen and
Table 2
Mean responses for telephone screening items
Depression screen Anhedonia screen
Yes No Yes No
# of MDD episodes 2.47 (2.55) 0.44 (1.07)⁎⁎ 1.81 (2.27) 0.83 (1.85)⁎⁎
Rumination 34.78 (7.58) 28.73 (6.63)⁎⁎ 34.50 (6.81) 28.39 (7.11)⁎⁎
DPI 35.72 (11.23) 25.60 (10.98⁎⁎ 35.39 (9.91) 24.90 (11.81)⁎⁎
Anhedonia 121.46 (11.25) 119.56 (17.12) 121.00 (12.96) 119.78 (16.55)
⁎⁎p<0.01, ⁎p<0.05.
Fig. 3. Rumination among males and females with and without endorsement of depressive history.
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69% of the time for the anhedonia screen. Such findings, in isolation, may initially suggest that the one-
item questions identify a probable MDD Hx better than 50% of the time.
Further data supporting the notion that the two screening questions reflect, to some degree, a MDD
vulnerability was shown in the findings that individuals who endorsed such items reported more stable,
latent, and endogenous MDD vulnerability characteristics when compared with those who did not endorse
the screening items. Consistent with this premise, those who endorsed the depression and anhedonia screens
had a greater number of prior episodes of clinically diagnosed MDD, reported greater levels of rumination
coping styles, and had higher scores on the depression-proneness inventory. Moreover, gender did not seem
to significantly influence these vulnerability characteristics with the exception of rumination. For those who
endorsed the depression screen, men reported higher levels of rumination compared with females.
In sum, the present paper provides preliminary support for the use of specific one-item questions that
tap into a MDD vulnerability. Although screening items did not correctly classify all participants with a
MDD Hx, results support the utility of at least the depression screen when comprehensive structured
interviews are not feasible. Future studies should incorporate these questions into large-scale studies in
order to increase generalizability and to assess the extent to which a depressive vulnerability hinders
cessation efforts. Such efforts would improve the ability to formulate more refined interpretations about
the impact of a history of MDD on smoking behavior and eventual cessation.
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